A Multicenter, Randomized, Double-Blind, Efficacy Study of Auriclosene Irrigation Solution on Indwelling Urinary Catheter Patency

Trial Profile

A Multicenter, Randomized, Double-Blind, Efficacy Study of Auriclosene Irrigation Solution on Indwelling Urinary Catheter Patency

Completed
Phase of Trial: Phase II

Latest Information Update: 19 Sep 2016

At a glance

  • Drugs Auriclosene (Primary)
  • Indications Bacterial infections; Catheter infections; Urinary tract infections
  • Focus Therapeutic Use
  • Sponsors NovaBay Pharmaceuticals
  • Most Recent Events

    • 19 Sep 2016 Primary endpoint has been met. (Percent flow rate reduction of study catheters at time of removal), as reported in a NovaBay Pharmaceuticals media release.
    • 19 Sep 2016 Results published in the Media Release
    • 01 Dec 2015 Planned End Date changed from 1 Dec 2016 to 1 Jan 2016 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top